-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R65z2w4kps+IEJD60/j38jYHYbq/Zm4gA7Wu/XefgNveG9o815HVFm/q7mMUxc4x K2/UD0y13v/gfqD1/n4pwg== 0001193125-09-223832.txt : 20091104 0001193125-09-223832.hdr.sgml : 20091104 20091104163449 ACCESSION NUMBER: 0001193125-09-223832 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091102 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20091104 DATE AS OF CHANGE: 20091104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KENSEY NASH CORP CENTRAL INDEX KEY: 0001002811 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 363316412 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34388 FILM NUMBER: 091158130 BUSINESS ADDRESS: STREET 1: 735 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105947156 MAIL ADDRESS: STREET 1: 735 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 2, 2009

 

 

Kensey Nash Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-34388   36-3316412

(State or other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

735 Pennsylvania Drive,

Exton, Pennsylvania

  19341
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (484) 713-2100

None

(Former name or former address if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At a meeting (the “Board Meeting”) of the Board of Directors (the “Board”) of Kensey Nash Corporation (the “Company”) on November 2, 2009, upon the recommendation of the Company’s Corporate Governance and Nominating Committee (the “Nominating Committee”), the Board approved, effective immediately prior to the election of directors at the Company’s 2009 annual meeting of stockholders (the “Annual Meeting”), which is scheduled to be held on December 9, 2009, the reassignment of Walter R. Maupay, Jr. and Harold N. Chefitz to classes of the Board different from their current classes (the “Reassignment”). Specifically: (1) Mr. Maupay, who currently serves as a member of the class of directors with a term expiring at the 2011 annual meeting of stockholders, is being moved into the class of directors being elected at the Annual Meeting; and (2) Mr. Chefitz, whose term expires at the Annual Meeting, is being appointed to fill a vacancy in the class of directors with a term expiring at the 2010 annual meeting of stockholders. In connection with the Reassignment, the Nominating Committee considered the current composition of the Board, the skills, experience and other qualifications of the Company’s current directors and the interplay of each director’s expertise and experience in light of the expertise and experience of the other members of the Board.

In connection with the Committee’s recommendation, and for the sole purpose of effectuating the Reassignment, Mr. Maupay delivered his resignation from the Board, effective immediately prior to the election of directors at the 2009 Annual Meeting. At the Board Meeting, the Board nominated Mr. Maupay for re-election at the Annual Meeting, to serve for a term of office expiring at the Company’s 2012 annual meeting of stockholders and until his successor is duly elected and qualified, or upon his earlier resignation or removal. Accordingly, given that Mr. Maupay’s resignation from the Board is effective immediately prior to the election of directors at the Annual Meeting and that Mr. Maupay is expected to be re-elected to the Board at the Annual Meeting, the Company expects that Mr. Maupay’s service on the Board will continue uninterrupted.

Further, to effect the Reassignment, Mr. Chefitz, rather than being nominated for re-election at the Annual Meeting, was appointed to fill a vacancy in the class of directors with a term of office expiring at the Company’s 2010 annual meeting of stockholders, effective at the time of the Annual Meeting. Currently Mr. Chefitz serves, and after giving effect to the Reassignment is expected to continue to serve, as a member of each of the Audit Committee and the Compensation Committee of the Board.

Additionally, Mr. Steven J. Lee, currently a member of the Board and each of the Audit Committee and the Compensation Committee of the Board, has decided to retire from the Board at the end of his current term, which expires at the Annual Meeting. As a result, Mr. Lee requested that he not be nominated for re-election to the Board at the Annual Meeting. Mr. Lee will continue to serve as a member of the Board and each of the Audit Committee and Compensation Committee until the Annual Meeting. Mr. Lee’s decision to retire from the Board was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

In connection with Mr. Lee’s service on the Board, Mr. Lee was issued 6,490 shares of restricted common stock of the Company issued by the Company to Mr. Lee on December 10, 2008, 2,164 shares of which would have vested on December 10, 2009, one day following the date of the Annual Meeting. In connection with Mr. Lee’s retirement from the Board, given that Mr. Lee will have served on the Board for his full term, including the entire period from the 2008 annual meeting of stockholders until the Annual Meeting, the Board determined that it is appropriate to vest these 2,164 shares of restricted common stock that would have vested one day following the Annual Meeting, and therefore these shares will no longer be subject to forfeiture. The remaining unvested shares of restricted stock of the Company previously issued by the Company to Mr. Lee will be forfeited back to the Company and will be cancelled. In addition, the Board agreed that all of the vested stock options held by Mr. Lee as of the date of the Annual Meeting will remain exercisable for a period of one-year following the date of the Annual Meeting.

 

1


After the Annual Meeting, giving effect to the Reassignment and the anticipated re-election of Messrs. Kaufmann and Maupay, the Board will consist of six directors, divided into three classes, each with two members, as follows:

 

Director

   Date Term Expires Prior to
Annual Meeting
   Date Term To Expire
After Annual Meeting

Joseph W. Kaufmann

   2009    2012

Walter R. Maupay, Jr.

   2011    2012

Steven J. Lee

   2009    —  

Harold N. Chefitz

   2009    2010

Robert J. Bobb

   2010    2010

Douglas G. Evans, P.E.

   2011    2011

C. McCollister Evarts, M.D.

   2011    2011

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  KENSEY NASH CORPORATION
  By:   /S/    MICHAEL CELANO        
  Name:   Michael Celano
  Its:   Chief Financial Officer
Dated: November 4, 2009    

 

3

-----END PRIVACY-ENHANCED MESSAGE-----